Investigational Site Number : 3920008

Bunkyo-ku, Tokyo 113-8677

1 studies enrolling now · 2 studies all time

What they study most

Allergic Fungal Rhinosinusitis, Immunoglobulin G4 Related Disease

Studies at this site

• A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease — Recruiting now
• Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI) — Completed